IMI – Clinical Management Guidelines Report

Kate L. Gifford, Kathryn Richdale, Pauline Kang, Thomas A. Aller, Carly S. Lam, Y. Maria Liu, Langis Michaud, Jeroen Mulder, Janis B. Orr, Kathryn A. Rose, Kathryn J. Saunders, Dirk Seidel, J. Willem L. Tideman, Padmaja Sankaridurg

Research output: Contribution to journalArticlepeer-review


Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed. The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.

Original languageEnglish
Article numberM184–M203
Pages (from-to)M184-M203
JournalInvestigative Ophthalmology and Visual Science
Issue number3
Publication statusPublished - 28 Feb 2019

Bibliographical note

Copyright 2019 The Authors. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License


  • Clinical considerations
  • Myopia control
  • Myopia progression
  • Patient communication
  • Practitioner education


Dive into the research topics of 'IMI – Clinical Management Guidelines Report'. Together they form a unique fingerprint.

Cite this